Search clinical trials for: 17-Hydroxyprogesterone Caproate 250 mg IM Dose

Total 201 results

Steve N. Caritis, MD
AMAG Pharmaceuticals, Inc.

Terminated

17-OHPC in Pregnancy: IM vs SC Routes

Preterm Birth

United States
Innovative Molecules GmbH

Recruiting

Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers

Herpes Simplex Virus

Germany
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery

Preterm Delivery

France
Steve N. Caritis, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Terminated

Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth (PRO)

Preterm Birth

United States
Assiut University

Completed

Progesterone in Expectantly Managed Early-onset Preeclampsia

Preeclampsia

Egypt
AMAG Pharmaceuticals, Inc.

Completed

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women

United States
University of South Florida
Washington University School of Medicine

Completed

17OHP-C Dosing Among Obese Pregnant Women

Premature Birth | Absorption; Chemicals

United States
AMAG Pharmaceuticals, Inc.

Terminated

Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women

United States
Lumara Health, Inc.

Completed

Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood

Pregnancy

United States
University of Pittsburgh
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Study of Pharmacology of 17-OHPC in Pregnancy

Pregnancy

United States
Yale University

Withdrawn

Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate

Premature Birth | Premature Labor
Lehigh Valley Hospital

Terminated

A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix

Mid Trimester Cervical Shortening

United States
The George Washington University Biostatistics...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)

Pregnancy | Preterm Birth | Multifetal

United States
The George Washington University Biostatistics...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Terminated

RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix (SCAN)

Cervical Length | Preterm Delivery

United States
The George Washington University Biostatistics...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies

Preterm Birth

United States
Saint Thomas Hospital, Panama

Unknown

Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone

Preterm Birth | Obstetric Labor, Premature

Panama
Meir Medical Center

Unknown

17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor

Pregnancy

Israel
University of North Carolina, Chapel Hill
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Improving Pregnancy Outcomes With Progesterone (IPOP)

HIV-1-infection | Pre-term Birth

Zambia
Obstetrix Medical Group

Completed

17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies (170HP)

Preterm Birth

United States
Soroka University Medical Center

Withdrawn

Progesterone for First Trimester Vaginal Bleeding

Premature Birth | Pre-Eclampsia | Fetal Growth Retardation | Threatened Abortion | Abruptio Placentae

Israel
University of Oklahoma

Completed

Comparing IM vs. Vaginal Progesterone for Pre-term Birth

Premature Birth | Infant, Premature

United States
Ain Shams University

Completed

Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes

Preterm Premature Rupture of Membrane

Egypt
Obstetrix Medical Group

Completed

Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM) (17PinPROM)

Preterm Delivery

United States
University of Modena and Reggio Emilia

Completed

Progestagens for the Tertiary Prophylaxis of Preterm Delivery (PROTECT)

Preterm Delivery | Neonatal Complications

Italy
American University of Beirut Medical Center

Completed

Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate

Preterm Delivery

Lebanon
Stanford University

Completed

Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.

Pregnancy Complications

United States
Tata Memorial Hospital
Ministry of Science and Technology, India

Completed

Primary Progesterone Therapy for Operable Breast Cancer

Breast Neoplasms

India
Assiut University

Completed

Intramuscular Hydroxyprogesterone Caproate and Placenta Previa

Preterm Labor

Egypt
AMAG Pharmaceuticals, Inc.
ResearchPoint Global

Completed

Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery (PROLONG)

Preterm Birth

United States, Spain, Russian Federation, Canada, Bulgaria, Czechia, Hungary, Italy, Ukraine
Bill & Melinda Gates Medical Research Institute

Not yet recruiting

Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population

Healthy Volunteers

Kenya, Uganda
Assaf-Harofeh Medical Center

Recruiting

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Ovarian Hyperstimulation Syndrome | Miscarriage | Pregnancy Early

Israel
Mayo Clinic

Completed

Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women

Healthy

United States
University of Sydney
Telethon Kids Institute; Bionet Co., Ltd; Technovalia; Institute for Clinical Pathology...

Completed

The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers (COVALIA)

SARS-CoV2 COVID-19

Australia
Thomas Jefferson University
Ohio State University; George Washington University; Baystate Medical Center; Vriginia...

Completed

Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth (VIP)

Premature Birth

United States
The Stone Research Foundation for Sports Medicine...

Enrolling by invitation

Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study

Trauma | Surgery | Complication of Surgical Procedure | Muscle Atrophy | Knee Injuries and Disorders

United States
Corcept Therapeutics

Completed

A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy Subjects

Healthy

United States
Ain Shams University

Unknown

Different Types of Progesterone in the Prevention of Preterm Labor

Preterm Labor

Egypt
Human Genome Sciences Inc.
GlaxoSmithKline

Completed

Study of Belimumab Administered Subcutaneously to Healthy Subjects

Healthy

United States
RespireRx

Completed

CX717 in the Treatment of Adult ADHD

Attention Deficit Hyperactivity Disorder
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

Influenza

China
Hoffmann-La Roche

Recruiting

Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. (Aldebaran)

Angelman Syndrome

United States, Australia, Spain, Italy, France, Germany
PHARMENTERPRISES LLC

Completed

Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascending Doses of XC243 After Single and Multiple Oral Administration in Healthy Volunteers.

Healthy Volunteers

Russian Federation
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Dyslipidemia Patients With Hypertension

Korea, Republic of
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film Coated Tablets (Pfizer Europe, Belgium)

Healthy

Egypt
Antares Pharma Inc.

Completed

Pharmacokinetic Study of Testosterone Enanthate

Hypogonadism

United States
Jazz Pharmaceuticals

Completed

Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease

Fatty Liver

United Kingdom
CTI BioPharma
PPD

Recruiting

Study to Evaluate the Safety, Tolerability, and PK of Pacritinib

Hepatic Impairment

United States
CymaBay Therapeutics, Inc.

Completed

Study to Evaluate the Effects of MBX-8025 in Patients With HoFH

Homozygous Familial Hypercholesterolemia

Canada, France, Netherlands, Norway
Supernus Pharmaceuticals, Inc.

Withdrawn

Classroom Study of SPN-812 in Children With ADHD

ADHD
Mirum Pharmaceuticals, Inc.

Completed

Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)

CTX

United States, Brazil

Search clinical trials for: 17-Hydroxyprogesterone Caproate 250 mg IM Dose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations